aging and cancer: the double-edged sword of cellular senescence and

36
Aging and Cancer: the Double-edged sword of cellular senescence And How to teach an old cell new tricks! Lawrence Berkeley National Laboratory and Buck Institute for Age Research

Upload: newton

Post on 06-Feb-2016

56 views

Category:

Documents


0 download

DESCRIPTION

Lawrence Berkeley National Laboratory and Buck Institute for Age Research. Aging and Cancer: the Double-edged sword of cellular senescence And How to teach an old cell new tricks!. INCIDENCE. AGE. Cancer Rises Exponentially with Age. Age is largest single risk factor - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Aging and Cancer: the  Double-edged sword of cellular senescence And

Aging and Cancer: the Double-edged sword of cellular senescence

And

How to teach an old cell new tricks!

Lawrence Berkeley National Laboratory and Buck Institute for Age Research

Page 2: Aging and Cancer: the  Double-edged sword of cellular senescence And

Cancer Rises Exponentially with Age

AGE

INC

IDE

NC

E

Age is largest single risk factorIncidence vs mortality

Page 3: Aging and Cancer: the  Double-edged sword of cellular senescence And

What Causes Cancer?

Mutations, mutations, mutations …

AND

A permissive tissue

Page 4: Aging and Cancer: the  Double-edged sword of cellular senescence And

Organisms with renewable tissueshad to evolve mechanisms

to prevent cancer

Tumor Suppressor Mechanisms

Page 5: Aging and Cancer: the  Double-edged sword of cellular senescence And

Tumor Suppressor Mechanisms/Genes

(eliminates or arrests potential cancer cells)

Apoptosis (programmed cell death)Cellular senescence

CARETAKERS Prevent or repair genomic damage

(prevent mutations)

GATEKEEPERS Control cellular responses to damage

Page 6: Aging and Cancer: the  Double-edged sword of cellular senescence And

Caretaker tumor suppressor genes arelongevity assurance genes

Gatekeeper tumor suppressor genes areantagonistically pleiotropic

Page 7: Aging and Cancer: the  Double-edged sword of cellular senescence And

Antagonistic Pleiotropy

What’s good for you when you are young,can be bad for you when you are old.

Page 8: Aging and Cancer: the  Double-edged sword of cellular senescence And

Aging before cell phones ……..

100%

SU

RV

IVO

RS

AGE

"Natural" Environment(hazards, predators, infection, etc.)

80 and >3-4

"Protected" Environment (climate control, biomedical intervention etc.)

40 yrsHUMANS:4 mos MICE:

Page 9: Aging and Cancer: the  Double-edged sword of cellular senescence And

Aging before cell phones ……..

100%S

UR

VIV

OR

S

AGE

"Natural" Environment(hazards, predators, infection, etc.)

"Protected" Environment (climate control, biomedical intervention etc.)

Mutation Accumulation

Antagonistic Pleiotropy

Page 10: Aging and Cancer: the  Double-edged sword of cellular senescence And

Cellular Senescence:A Gatekeeper Tumor Suppressor

Induced by potentially oncogenic stimuli

Most tumor cells acquire mutations that abrogate the senescence response

Controlled by p53 and pRB -- tumor suppressorsinactivated in most tumors

Mouse models/human cancer-prone syndromes

Page 11: Aging and Cancer: the  Double-edged sword of cellular senescence And

Short/dysfunctionaltelomeres

(REPLICATIVE SENESCENCE)

DNADamage Oncogenes

ChromatinInstability

Stress/Signals

Cellular Senescence: Induced by Potentially Cancer-Causing Events

Irreversiblearrest of

cell proliferation

Page 12: Aging and Cancer: the  Double-edged sword of cellular senescence And

The senescence response

is not simply an arrest of

cell growth

Page 13: Aging and Cancer: the  Double-edged sword of cellular senescence And

The Senescent Phenotype

IrreversibleGrowth Arrest

Resistanceto

Apoptosis

AlteredDifferentiated

Functions

Page 14: Aging and Cancer: the  Double-edged sword of cellular senescence And

Selected/Unselected (deleterious) Traits

IrreversibleGrowth Arrest

Resistanceto

Apoptosis

AlteredDifferentiated

Functions

Cellular Senescence and Antagonistic Pleiotropy

Unselected traits of little consequence, unless senescent cells accumulate to appreciable levels

Page 15: Aging and Cancer: the  Double-edged sword of cellular senescence And

Senescent Cells Accumulate In Vivo

With Increasing AgeSkin

RetinaLiver

At Sites of Age-Related PathologyVenous ulcers

Atherosclerotic plaquesBenign prostatic hyperplasiaPreneoplastic hepatic lesions

Page 16: Aging and Cancer: the  Double-edged sword of cellular senescence And

Senescent Cells May Contribute to Aging Phenotypes/Diseases …….

Including Cancer

Page 17: Aging and Cancer: the  Double-edged sword of cellular senescence And

Ana KrtolicaSimona Parrinello

Steve Lockett - LBNL Imaging Group

Pierre Desprez - CPMC

Proc. Natl Acad. Sci USA 98:12072-12077 (2001)

Page 18: Aging and Cancer: the  Double-edged sword of cellular senescence And

Ep

ith

elia

l F

luo

resc

ence

HaCAT SCp2 S1

Senescent Fibroblasts Stimulate the Proliferation of Premalignant Epithelial Cells

Premalignant Epithelial Cells

Fibroblasts:Presenescent

Senescent

Page 19: Aging and Cancer: the  Double-edged sword of cellular senescence And

Ep

ith

elia

l F

luo

resc

ence

AdultNHEK

Neonatal NHEK

Adult HMEC

Senescent Fibroblasts Do NOT Stimulate Normal Epithelial Cells

Fibroblasts:Presenescent

Senescent

Genetically Normal Human Epithelial Cells

Page 20: Aging and Cancer: the  Double-edged sword of cellular senescence And

Senescent Fibroblasts Stimulate Tumorigenesis of Premalignant Epithelial Cells In Vivo

Days40 80 120

Tu

mo

r si

ze (

mm

3 x

10)

100

0

100

0

200

100

0

200

SCp2 cells alone

+ Presenescent Fibroblasts

+ Senescent Fibroblasts

Page 21: Aging and Cancer: the  Double-edged sword of cellular senescence And
Page 22: Aging and Cancer: the  Double-edged sword of cellular senescence And

Christian BeausejourAna Krtolica

Francesco Galimi (Verma lab, Salk Institute)Masasha Narita, Scott Lowe (CSH)

Paul Yaswen (LBNL)

EMBO J 22:4212-4222 (2003)

Page 23: Aging and Cancer: the  Double-edged sword of cellular senescence And

Senescence Response, Controlled by p53 and pRB Pathways

p53 pRB

Growth Arrest + Senescent Gene Expression

Tx Changes(downstream effectors)

ARF

MDM2

CDK4

p16

Page 24: Aging and Cancer: the  Double-edged sword of cellular senescence And

Lentiviruses for high-efficiency expression of genes in senescent cells

Lenti-GSE (inactivates p53)

Lenti-CDK4m (inactivates pRB)

Lenti-p16 (activates pRB)

Lenti-p16(RNAi) (inactivates pRB)

p53 pRB

ARF

MDM2

CDK4

p16

Page 25: Aging and Cancer: the  Double-edged sword of cellular senescence And

SenescentBJ

(foreskin fb)

SenescentWI-38

(fetal lung fb)

+ Lenti-GSE (inactivate p53)

20 DoublingsNo proliferation

Page 26: Aging and Cancer: the  Double-edged sword of cellular senescence And

0

20

40

60

80

100

0 20 40 60 80 1000

5

10

15

20

25

GSE

LgT

LgTK1

CDK4

GF

Ph

TE

RT

GS

E

Lg

T

Lg

TK

1

GS

E+

Lg

T

% L

N

S-BJ

% GROWTH: 0 0 >90 60 40 >90 20*

Po

pu

lati

on

do

ub

lin

g

Days post infection

S-BJ rescuedC

DK

4

0

20

40

60

80

100

GF

P

hT

ER

T

GS

EL

gT

Lg

TK

1G

SE

+L

gT

% L

N

S-WI

CD

K4

CD

K4

+G

SE

% GROWTH: 0 0 <1 <1 <1 <1 0 <1

GSE

LgT, LgT[K1]

CDK4m

Page 27: Aging and Cancer: the  Double-edged sword of cellular senescence And

p53 inactivation can reverse the senescent growth arrest of BJ, but not WI-38, cells

What distinguishes reversiblyfrom irreversibly senescent

cells??

Page 28: Aging and Cancer: the  Double-edged sword of cellular senescence And

Fibroblasts differ in expressionof p16 at senescence:

BJ = low p16WI38 = high p16

BJ WI38 P S P S

actin

p16

pRBCDK4

p16

Page 29: Aging and Cancer: the  Double-edged sword of cellular senescence And

Do differences in p16 expression

explain differences in

reversibility of the senescence arrest?

Page 30: Aging and Cancer: the  Double-edged sword of cellular senescence And

Presenescent BJ fibroblasts (low p16):

DNA synthesis, but no proliferation

0

40

80

100

% g

row

th

GFP p16 p16+

GSE

p16+

LgT

LgT +GFP

LgT +p16

1) + lenti-p16

2) + lenti-GSE

Page 31: Aging and Cancer: the  Double-edged sword of cellular senescence And

Presenescent WI-38 fibroblasts (high p16):

DNA synthesis + proliferation

0

40

80

100%

gro

wth

GFP p16RNAi + Sn

p16RNAi

+Sn +

GSE

Sn +GFP +LgT

Sn +p16RNA +LgT

p16RNAi

+Sn+

LgT

1) + lenti-p16-RNAi ----> Senescence

2) + lenti-GSE

Page 32: Aging and Cancer: the  Double-edged sword of cellular senescence And

p53 maintains the senescent state; p16 maintains a dominant barrier to reversal

The senescent phenotype is reversibleupon p53 inactivation ……

Providing the p16/pRB pathway hasnot been engaged

Why does p16 render the senescencegrowth arrest irreversible?

Page 33: Aging and Cancer: the  Double-edged sword of cellular senescence And

HYPOTHESIS: p16 enables pRB toestablish an “irreversibly” repressive

chromatin state that, once established,is independent of p16 or pRB

Senescent cells form RB-dependent heterochromaticdomains that repress positive acting cell cycle genes

Lowe and colleagues, Cell, 2003

Once cells express high levels of p16, they nolonger require p16 or active pRB to maintain the

senescence growth arrest

Page 34: Aging and Cancer: the  Double-edged sword of cellular senescence And

p16 renders senescence irreversible

0

40

80

100

% g

row

thGFPp16 p16

+GSE

p16+

LgT

LgT +GFP

LgT +p16

PBJ +p16

0

40

80

100

% g

row

th

GFPp16RNAi + Sn

p16RNAi

+Sn +

GSE

Sn +GFP +LgT

Sn +p16RNAi +LgT

p16RNAi

+Sn+

LgT

PWI +P16-RNAi

Page 35: Aging and Cancer: the  Double-edged sword of cellular senescence And

Senescence is not necessarily irreversiblein human cells

Hint: ask about mouse cells!

p53 inactivation is not a recommended therapy(but p53 modifiers, such as SIR2, may be!)

What determines the extent to which cells express p16?

How can we reverse thep16/pRB-initiated chromatin?

Page 36: Aging and Cancer: the  Double-edged sword of cellular senescence And

Aging and Tumor Suppression

Tumor suppressors

Aging Phenotypes Cancer

Can tumor suppression and agingbe uncoupled??